Skip to content

A Clinical Study to Evaluate The Effect Of Palasa Twak Kashaya and Saptasara Kwatha in Udavarthini Yonivyapat.

A Comparative Clinical Study to Evaluate The Effect of Palasa Twak Kashaya and Saptasara Kwatha in Udavarthini Yonivyapat.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044508
Enrollment
40
Registered
2022-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea Health Condition 2: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

MOBIN KHAN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients fulfilling the diagnostic criteria. 2.The age group between 16-25 years. 3. H/O Painful menstruation for at least 3 consecutive menstrual cycles. 4.Patients with regular menstrual cycle.

Exclusion criteria

Exclusion criteria: 1.Cases OF secondary dysmenorrhoea with pelvic pathology like ovarian cyst, fibroid uterus and endometriosis. 2.Patients on hormonal therapy. 3.Patients with vaginal atresia,cervical stenosis and retroverted uterus. 4.Patients with systemic disease. 5.Patients with IUCD.

Design outcomes

Primary

MeasureTime frame
The Changes In The Symptoms Before And After The Medication Will Be Scored. Pain will be assessed by VAS grading (VISUAL ANALOGUE SCALE)Timepoint: The Changes In The Symptoms Before And After The Medication Will Be Scored. Pain will be assessed by VAS grading (VISUAL ANALOGUE SCALE) Assessment for 8 weeks

Secondary

MeasureTime frame
Pre and post intervention assessment will be done. Symptoms like pain will be graded on VAS scale and score will be given accordingly.Timepoint: Treatment will be started 7 days before expected menstruation and continued up to another 3 days. Assessment-Will be done before treatment and on the 4th day of each menstrual cycle for 2 consecutive cycles. Post treatment follow up-on the 4th day of 3rd cycle.

Countries

India

Contacts

Public ContactDr Sumarani Rajesh M

Alvas Ayurveda Medical College

drsumaranirajesh@gmail.com9449664617

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026